The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline
- 2.6k Downloads
Goals of work
To develop a practice guideline report on the questions: What are the optimal methods to prevent acute skin reactions (occurring within the first 6 months of irradiation) related to radiation therapy? What are the optimal methods to manage acute skin reactions related to radiation therapy?
Materials and methods
Cancer Care Ontario’s Supportive Care Guidelines Group (SCGG) conducted a systematic review of literature on this topic. Evidence-based recommendations were formulated to guide clinical decision making, and a formal external review process was conducted to validate the relevance of these opinions for Ontario practitioners.
Twenty-eight trials meeting the inclusion criteria were identified. Of the twenty-three trials that evaluated preventative methods, washing was the only practice which significantly prevented skin reaction. Some evidence suggested topical steroid creams and calendula ointment might be effective. None of the five trials evaluating skin reaction management detected a positive effect using steroid cream, sucralfate cream, or dressings.
Skin washing, including gentle washing with water alone with or without mild soap, should be permitted in patients receiving radiation therapy to prevent acute skin reaction. There is insufficient evidence to support or refute specific topical or oral agents for the prevention or management of acute skin reaction. In the expert opinion from the SCGG, the use of a plain, non-scented, lanolin-free hydrophilic cream may be helpful in preventing radiation skin reactions. In addition, a low dose (i.e., 1%) corticosteroid cream may be beneficial in the reduction of itching and irritation.
KeywordsPractice guideline Systematic review Acute skin reactions Radiation therapy
The PEBC is sponsored by, but editorially independent of, Cancer Care Ontario and the Ontario Ministry of Health and Long-Term Care.
The SCGG would like to thank Ms. Karima Velji for her contribution during the initial stages of the development of the guideline and Ms. Julie Wilson for assisting in the preparation of this manuscript.
- 5.British Columbia Cancer Agency (2000) Cancer management manual: supportive care—guidelines for the care of radiation skin reactions. Available at: http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/SupportiveCare/RadiationSkinReactions/default.htm. Accessed: February 18, 2004
- 10.Canadian Cancer Society (2003) [document online]. Available at: http://www.cancer.ca/ccs/internet/standard/0,3182,3172_369269_429281_langId-en,00.html. Accessed: November 17, 2003
- 16.Fisher J, Scott C, Stevens R et al (2000) Randomized phase III study comparing best supportive care to biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: radiation therapy oncology group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 48:1307–1310PubMedGoogle Scholar
- 20.Hazuka MB, Goebel RH, McCutchan S et al (1997) A new approach to the prevention of radiation-induced skin desquamation using a polymer adhesive skin sealant (PASS): final results of a prospective study (meeting abstract). Proc Am Soc Clin Oncol 16:A239Google Scholar
- 33.Oncology Nursing Society (ONS) (1998) Manual for radiation oncology nursing practice and education. Oncology Nursing Society, Pittsburgh, PAGoogle Scholar
- 34.Perez CA, Brady LW (1998) Principles and practice of radiation oncology, 3rd edn. Lippincott-Raven, Philadelphia, PA, p 11Google Scholar
- 36.Potera ME, Lookingbill DP, Stryker JA (1982) Prophylaxis of radiation dermatitis with a topical cortisone cream. Radiother Oncol 143:775–777Google Scholar
- 42.Snyder CC (1986) Oncology nursing. Little, Brown and Company, Boston, MAGoogle Scholar
- 43.Snyder DS, Greenberg RA (1977) Radiographic measurement of topical corticosteriod-induced atrophy. J Invest Dermatol 279–281Google Scholar
- 44.Szumacher E, Wighton A, Franssen E et al (2001) Phase II study assessing the effectiveness of biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy. Int J Radiat Oncol Biol Phys 51:81–86PubMedGoogle Scholar